KINGWORLD terminates acquisition MOU, seeks HK$3.32 million deposit refund

Bulletin Express
Jun 15

Hong Kong-listed Kingworld Medicines Group Limited (KINGWORLD) has cancelled its memorandum of understanding (MOU) for a proposed full acquisition of an unnamed target company.

The MOU, signed on 22 January 2026 between wholly-owned subsidiary Kingworld Medicine and Healthcare Group Limited (BVI), the intended vendor and its guarantors, granted either party the right to terminate under specified conditions. Exercising this right, the subsidiary ended the agreement with immediate effect on 15 June 2026.

Upon termination, KINGWORLD demanded the return of the HK$3.32 million deposit within five business days from 15 June 2026.

The board stated that ending the MOU will not have any material adverse impact on the group’s current financial position or operations. Nonetheless, shareholders and potential investors were advised to exercise caution when dealing in the company’s shares.

Disclaimer: Investing carries risk. This is not financial advice. The above content should not be regarded as an offer, recommendation, or solicitation on acquiring or disposing of any financial products, any associated discussions, comments, or posts by author or other users should not be considered as such either. It is solely for general information purpose only, which does not consider your own investment objectives, financial situations or needs. TTM assumes no responsibility or warranty for the accuracy and completeness of the information, investors should do their own research and may seek professional advice before investing.

Most Discussed

  1. 1
     
     
     
     
  2. 2
     
     
     
     
  3. 3
     
     
     
     
  4. 4
     
     
     
     
  5. 5
     
     
     
     
  6. 6
     
     
     
     
  7. 7
     
     
     
     
  8. 8
     
     
     
     
  9. 9
     
     
     
     
  10. 10